VACCITECH (SP.ADR)/1 (2AB) - Total Liabilities

Latest as of March 2026: €25.66 Million EUR ≈ $30.01 Million USD

Based on the latest financial reports, VACCITECH (SP.ADR)/1 (2AB) has total liabilities worth €25.66 Million EUR (≈ $30.01 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore VACCITECH (SP.ADR)/1 (2AB) cash conversion ratio to assess how effectively this company generates cash.

VACCITECH (SP.ADR)/1 - Total Liabilities Trend (2021–2025)

This chart illustrates how VACCITECH (SP.ADR)/1's total liabilities have evolved over time, based on quarterly financial data. See 2AB net assets for net asset value and shareholders' equity analysis.

VACCITECH (SP.ADR)/1 Competitors by Total Liabilities

The table below lists competitors of VACCITECH (SP.ADR)/1 ranked by their total liabilities.

Company	Country	Total Liabilities
Sikko Industries Limited NSE:SIKKO	India	Rs493.72 Million
Yorbeau Resources Inc TO:YRB	Canada	CA$479.62K
PC Direct Inc KQ:051380	Korea	₩61.56 Billion
Pure Hydrogen Corporation Ltd AU:PH2	Australia	AU$10.49 Million
Bangsaphan Barmill Public Company Limited BK:BSBM	Thailand	฿18.33 Million
Form Bio Co. Ltd. KQ:377220	Korea	₩38.97 Billion
Telefast Indonesia JK:TFAS	Indonesia	Rp42.65 Billion
exax Inc KQ:060230	Korea	₩88.82 Billion

Liability Composition Analysis (2021–2025)

This chart breaks down VACCITECH (SP.ADR)/1's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of VACCITECH (SP.ADR)/1.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.05	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.39	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how VACCITECH (SP.ADR)/1's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for VACCITECH (SP.ADR)/1 (2021–2025)

The table below shows the annual total liabilities of VACCITECH (SP.ADR)/1 from 2021 to 2025.

Year	Total Liabilities	Change
2025-12-31	€23.88 Million ≈ $27.91 Million	-20.92%
2024-12-31	€30.19 Million ≈ $35.30 Million	+9.75%
2023-12-31	€27.51 Million ≈ $32.16 Million	+1.88%
2022-12-31	€27.00 Million ≈ $31.57 Million	-4.08%
2021-12-31	€28.15 Million ≈ $32.91 Million	--

About VACCITECH (SP.ADR)/1

F:2AB Germany Biotechnology

Market Cap

$24.11 Million

€20.62 Million EUR

Market Cap Rank

#25060 Global

#2170 in Germany

Share Price

€0.51

Change (1 day)

+5.65%

52-Week Range

€0.45 - €1.54

All Time High

€14.00